Manufacturing PMI – Europe | March 2026
- Eurozone: 51.6 (forecast: 51.4; previous: 51.4)
- Germany: 52.2 (forecast: 51.7; previous: 51.7)
- Italy: 51.3 (forecast: 50.9; previous: 50.6)
- France: 50.0 (forecast: 50.2; previous: 50.2)
- Switzerland: 53.3 (forecast: 47.0; previous: 47.4)
- Spain: 48.7 (forecast: 50.4; previous: 50.0)
- Sweden: 56.3 (previous: 56.1)
- Poland: 48.7 (forecast: 47.2; previous: 47.1)
March PMI data for European manufacturing delivered broadly positive surprises, although the overall picture remains mixed. The eurozone as a whole recorded a reading of 51.6, above both expectations and the previous month, signaling continued expansion in the manufacturing sector. The standout surprise was Switzerland, with a reading of 53.3 versus expectations of just 47.0—one of the largest positive deviations from consensus on record. Germany is reinforcing its role as the engine of European industry, posting 52.2 and clearly beating forecasts, suggesting the region’s largest economy is emerging from a prolonged period of weakness.
On the downside, Spain disappointed by falling below the 50 threshold (48.7 vs. 50.4 expected), indicating a contraction in manufacturing activity after a month of growth. Poland saw a modest improvement to 48.7, outperforming expectations (47.2), but remains in contraction territory—marking yet another month below the 50 level. Overall, the data carries a moderately positive tone for the euro, although the clear divergence between core economies and the periphery may complicate a unified assessment of the eurozone’s condition by the ECB.
Source: xStation
AU200.cash: mixed signals from the Australian economy โ๏ธ
Morning wrap (01.04.2026)
Daily Summary: Markets Explode ๐ Investors Price in the End of the War ๐ค
BREAKING: Markets surge following the Iranian president's statement about a possible end to the conflict ๐จ
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
